Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milan Radovich

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
Pharmacogenomics|April 21, 2012
Next-generation sequencing in breast cancer: translational science and clinical integrationMilan Radovich
Antioxidants & Redox Signaling|December 17, 2013
Methods of quantifying microRNAs for hypoxia research: classic and next generationMilan Radovich, Jiannis Ragoussis
Oncology (Williston Park, N.Y.)|March 15, 2014
TCGA's breast cancer project may yield important therapeutic benefits, but it's too early to be sureMilan Radovich, George W Sledge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
The role of vascular endothelial growth factor genetic variability in cancerBryan P Schneider, Milan Radovich, Kathy D Miller
JCO Precision Oncology|January 20, 2022
Precision Prevention: The Current State and Future of Genomically Guided Cancer PreventionNawal Kassem, Leigh Anne Stout, Cynthia Hunter, et al.
The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.
JCO Precision Oncology|February 9, 2022
Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair DeficiencyPatrick J Kiel, Milan Radovich, Bryan P Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158Tarah J Ballinger, Guanglong Jiang, Nawal Kassem, et al.
NAR Genomics and Bioinformatics|November 3, 2021
ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathwaysXiaoqing Huang, Kun Huang, Travis Johnson, et al.
Scientific Reports|July 2, 2021
Identification of germline cancer predisposition variants during clinical ctDNA testingLeigh Anne Stout, Nawal Kassem, Cynthia Hunter, et al.
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
Pharmacogenomics|April 21, 2012
Next-generation sequencing in breast cancer: translational science and clinical integrationMilan Radovich
Antioxidants & Redox Signaling|December 17, 2013
Methods of quantifying microRNAs for hypoxia research: classic and next generationMilan Radovich, Jiannis Ragoussis
Oncology (Williston Park, N.Y.)|March 15, 2014
TCGA's breast cancer project may yield important therapeutic benefits, but it's too early to be sureMilan Radovich, George W Sledge
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2009
The role of vascular endothelial growth factor genetic variability in cancerBryan P Schneider, Milan Radovich, Kathy D Miller
JCO Precision Oncology|January 20, 2022
Precision Prevention: The Current State and Future of Genomically Guided Cancer PreventionNawal Kassem, Leigh Anne Stout, Cynthia Hunter, et al.
The Oncologist|August 6, 2017
Exceptional Response with Immunotherapy in a Patient with Anaplastic Thyroid CancerRevathi Kollipara, Bryan Schneider, Milan Radovich, et al.
JCO Precision Oncology|February 9, 2022
Sustained Exceptional Response to Poly (ADP-Ribose) Polymerase Inhibition Plus Temozolomide in Metastatic Melanoma With DNA Repair DeficiencyPatrick J Kiel, Milan Radovich, Bryan P Schneider, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158Tarah J Ballinger, Guanglong Jiang, Nawal Kassem, et al.
NAR Genomics and Bioinformatics|November 3, 2021
ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathwaysXiaoqing Huang, Kun Huang, Travis Johnson, et al.
Scientific Reports|July 2, 2021
Identification of germline cancer predisposition variants during clinical ctDNA testingLeigh Anne Stout, Nawal Kassem, Cynthia Hunter, et al.
Pageof 11